Aligos Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Aligos Therapeutics

12/03/2024 21:56

* Aligos Therapeutics Inc  ALGS.OQ  reported a quarterly
adjusted
loss of 22 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -51 cents.  The mean expectation of two analysts
for the quarter was for a loss of 27 cents per share. Wall
Street expected results to range from -43 cents to -11 cents per
share.
    * Revenue fell 43.2% to $2.01 million from a year ago;
analysts
expected $1.60 million. 
    * Aligos Therapeutics Inc's reported EPS for the quarter was
a
loss of 22 cents​.
    * The company reported a quarterly loss of $27.89 million.
    * Aligos Therapeutics Inc shares had risen by 32.5% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 3.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is  "hold."

Wall Street's median 12-month price target for Aligos
Therapeutics Inc is $4.00 
This summary was machine generated from LSEG data March 12 at
09:55 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.27          -0.22          Beat
 Sep. 30 2023      -0.47          -0.41          Beat
 Jun. 30 2023      -0.49          -0.43          Beat
 Mar. 31 2023      -0.48          -0.53          Missed